Description
Jason T. Jacobson, MD, FHRS, of Westchester Med Center-New York Med College discusses A Novel ECG-Based Deep Learning Algorithm to Predict Cardiomyopathy in Patients With Premature Ventricular Complexes with Daniel Frenkel, MD, FHRS, of Westchester Medical Center, and Jagmeet P. Singh, MD, PhD, FHRS, of Massachusetts General Hospital. This study utilized a machine learning algoritihm to predict the devlopment of cardiomyopathy in patients with PVCs based on the baseline ECG.
Learning Objectives
- To identify predictors of development of cardiomyopathy in patients with PVCs.
Article Authors and Podcast Contributors
Article Authors
Joshua Lampert, MD, Akhil Vaid, MD, William Whang, MD, Jacob Koruth, MBBS, Marc A. Miller, MD, Marie-Noelle Langan, MD, Daniel Musikantow, MD, Mohit Turagam, MD, Abhishek Maan, MD, Iwanari Kawamura, MD,aSrinivas Dukkipati, MD, Girish N. Nadkarni, MD, Vivek Y. Reddy, MD
Podcast Contributors
Jason T. Jacobson, MD, FHRS, of Westchester Med Center-New York Med College
Daniel Frenkel, MD, FHRS, of Westchester Medical Center
Jagmeet P. Singh, MD, PhD, FHRS, of Massachusetts General Hospital
Disclosures
All relevant financial relationships have been mitigated.Host Disclosure(s):
J. Jacobson: Honoraria/Speaking/Consulting Fee: American College of Cardiology, Zoll Medical Corporation; Research (Contracted Grants for PIs Named Investigators Only): Abbott, Phillips; Stocks (Privately Held): Atlas 5D
Contributor Disclosure(s):
D. Frenkel: Ownership/Partnership/Principal: Summit HealthJ. Singh: Honoraria/Speaking/Consulting Fee: Medtronic, EBR Systems, Boston Scientific, Biotronik, Abbot, MicroPort Scientific Corporation, Cardiologs, Sanofi, CVRx Inc., Impulse Dynamics, USA, Implicity, Orchestra Biomed, Rhythm Management Group Corp, Medscape, Biosense Webster Inc., Notal Vision, iRhythm Technologies, Philips
Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
J. Glenn: No relevant financial relationships with ineligible companies to disclose.
S. Sailor: No relevant financial relationships with ineligible companies to disclose.